What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class II recall affecting a specific medical device manufactured by Fresenius Medical Care Renal Therapies Group, LLC. This action targets the 5008X Standard HD Pre-Flush Standard Blood Tubing Set, identified by Part Number 03-5110-6. To understand exactly what is involved, it helps to look at the context of this product. These tubing sets are critical components used in hemodialysis treatments, a life-sustaining procedure for individuals with kidney failure. The device connects patients to dialysis machines, facilitating the flow of blood out of the body, through a filter to remove waste and excess fluid, and back into the body. Because these sets are single-use items designed for direct interaction with a patient’s circulatory system during treatment, any structural or material defect in their construction can have immediate and serious clinical consequences.
The scope of this recall is defined by precise lot numbers and Universal Device Identification (UDI) codes, which allow healthcare providers and patients to verify exactly which units are affected. The recalled inventory includes tubing sets from Lots 25KR01227 and 25NR01257. These specific lots are associated with the UDI-DI code 00840861102556. It is important to note that the official recall documentation does not explicitly state the total number of units involved in this distribution, nor does it provide a detailed breakdown of how many sets were shipped to each specific location. Therefore, verification must be done by checking the lot numbers printed on the individual product packaging or labels against the two lots listed above.
The distribution pattern for these recalled items indicates that they were sold worldwide, with a significant presence across the United States. In the U.S., the products were distributed nationwide, specifically reaching states including Alabama, California, Colorado, Florida, Georgia, Illinois, Kentucky, Louisiana, Massachusetts, Maryland, Minnesota, Missouri, North Carolina, New Hampshire, New York, Ohio, Pennsylvania, Tennessee, Texas, and Virginia. The recall also notes distribution to the country of Lithuania. The official date listed for this recall action by the FDA is August 10, 2026. If you or a loved one receives dialysis treatment, particularly in any of the states mentioned, it is vital to check the specific lot numbers on the tubing sets used during recent sessions to ensure they are not part of this affected batch.
The hazard, explained
To understand why this recall matters, we first need to look at how hemodialysis works and where the specific failure point lies in the Fresenius Medical Care 5008X Standard HD Pre-Flush Standard Blood Tubing Set (Part Number 03-5110-6). During a standard dialysis treatment, a patient’s blood is pumped out of their body, through a machine that filters it, and then returned. This process relies on a closed loop of tubing to keep the blood contained and sterile. In this particular setup, the "Arterial Alpha Clip" serves as a critical connection point where the main line or pump segment attaches to the rest of the circuit.
The core issue identified by the FDA is a heightened probability that blood will leak from this specific junction between the Arterial Alpha Clip and either the main line or the pump segment. In engineering terms, this suggests that the seal or mechanical lock intended to keep these two plastic components tightly joined may not be holding up under the pressure of blood flow. When the clip fails to maintain a watertight (or rather, blood-tight) seal, the pressurized blood inside the tube escapes into the external environment rather than staying within the closed system.
This is not just a minor mess; it is a serious medical event. When blood leaks out of the circuit during treatment, the patient experiences an active loss of volume. In medical terms, this is known as hemorrhage. If the leak is significant or goes unnoticed for even a short period, the patient can lose enough blood to trigger hypovolemia. Hypovolemia occurs when there is too little blood in the body to maintain adequate pressure and circulation to vital organs. This condition can lead to dangerous drops in blood pressure, dizziness, fainting, shock, or in severe cases, organ failure.
The danger here is compounded by the nature of dialysis itself. Patients undergoing this treatment are often already medically fragile, with compromised cardiovascular systems that may not tolerate sudden changes in blood volume well. Furthermore, because the leak occurs at a connection point that might be partially obscured or situated near other components, it can sometimes be difficult to detect immediately during a long treatment session. A slow leak might be mistaken for normal fluid accumulation or condensation until significant blood loss has already occurred.
While this specific hazard is tied to the manufacturing or design variance in the 5008X tubing sets distributed nationwide and in Lithuania, it highlights a broader reality about medical devices: even small mechanical failures in high-pressure systems can have outsized consequences. The FDA’s classification of this as a Class II recall indicates that while the situation is serious and requires immediate attention to prevent health problems, it is not typically life-threatening if addressed promptly. However, ignoring the potential for blood loss at the arterial connection point is never an option when you are dependent on external filtration for your kidney function.
Who is most at risk
To understand who is truly at risk in this situation, we first need to look at the specific nature of the product involved. This recall concerns the Fresenius Medical Care 5008X Standard HD Pre-Flush Standard Blood Tubing Set, specifically part number 03-5110-6. This is not a household item found in grocery stores or typical medical supply shops for general use. It is a specialized component designed exclusively for use with hemodialysis machines. Therefore, the primary group of people at risk are patients undergoing regular dialysis treatments, particularly those who rely on standard high-flux (HD) dialysis protocols that require pre-flush capabilities. These individuals are typically in care facilities or home-care settings where medical professionals manage their treatment schedules.
The specific hazard identified here is a heightened probability of blood leaking from the connection between the Arterial Alpha Clip and the main line or pump segment. For a healthy person, a minor leak might be an inconvenience. However, for a dialysis patient, this is a critical safety failure. The risk is not about the device breaking in a way that renders it useless; rather, it is about the silent loss of blood volume during a procedure. When blood leaks from the connection points during treatment, it leads directly to blood loss. Over the course of a single session, or across multiple sessions using these defective lots, this can result in hypovolemia—a condition where there is too little blood in the body to maintain adequate pressure and flow.
Within the population of dialysis patients, certain demographics are more vulnerable to the consequences of hypovolemia. Elderly patients, who often have less physiological reserve, may struggle to recover from sudden drops in blood volume. Individuals with pre-existing cardiovascular conditions are also at heightened risk, as their hearts may not be able to compensate for the reduced blood volume quickly enough. For these patients, the stress on the circulatory system caused by unexpected blood loss can lead to dizziness, fainting, or more severe cardiac events during a treatment that is already demanding on the body.
It is also important to note that while the distribution pattern includes states such as Alabama, California, Florida, and New York, as well as Lithuania, the risk is confined to those who have received units from the specific lots mentioned in the FDA notice: 25KR01227 and 25NR01257. If you are a patient or a healthcare provider handling this equipment, your risk level depends entirely on whether these specific tubing sets have entered your treatment environment. The vulnerability is highest for those undergoing active treatment with these units, as the leak occurs during the procedure itself, leaving little time for intervention before blood loss has occurred.
How to tell if you have the recalled item
If you are a patient undergoing hemodialysis or work in a dialysis clinic, verifying whether you have been exposed to this specific recall requires careful attention to several distinct identifiers. The product in question is the 5008X Standard HD Pre-Flush Standard Blood Tubing Set, manufactured by Fresenius Medical Care under their Renal Therapies Group. Because medical supplies often look similar at a glance, relying on visual cues alone is not enough; you must cross-reference the physical markings on the packaging or the device itself with the specific data points listed in the FDA notice.
The most critical identifier to check is the Part Number. You need to locate the label that clearly displays "Part Number 03-5110-6." This alphanumeric code is unique to this specific configuration of the tubing set. If the part number on your box or the sterile wrapper differs, even slightly, it is likely a different product and not subject to this particular recall action. Alongside the part number, you must verify the Lot Numbers. The FDA has identified two specific lots as affected by this safety concern: "25KR01227" and "25NR01257." These numbers are typically printed on the outer packaging or the individual sterile pouches. If your supply does not match one of these exact lot codes, it is not part of this recall.
For those who need to verify inventory through digital systems or track individual items more precisely, you should also look for the Unique Device Identifier (UDI). The UDI-DI associated with this recalled item is "00840861102556." This code helps in scanning and tracking the device throughout its distribution chain. While the visual appearance of a standard blood tubing set may vary by color or size depending on clinic preferences, the textual data remains the definitive proof of whether an item is recalled.
It is also important to consider where and when these items were distributed to help narrow down your search. Although this recall has worldwide implications, the distribution pattern specifically notes that these units were distributed nationwide in the United States. If you are located in any of the following states, there is a possibility that supplied equipment falls under this recall: Alabama (AL), California (CA), Colorado (CO), Florida (FL), Georgia (GA), Illinois (IL), Kentucky (KY), Louisiana (LA), Massachusetts (MA), Maryland (MD), Minnesota (MN), Missouri (MO), North Carolina (NC), New Hampshire (NH), New York (NY), Ohio (OH), Pennsylvania (PA), Tennessee (TN), Texas (TX), and Virginia (VA). Additionally, distribution extended to Lithuania. If you are in one of these regions and have recently received or used Fresenius Medical Care tubing sets, double-check the part number and lot numbers immediately. Do not rely on memory or general brand recognition; always verify the specific codes printed on the packaging.
What to do — step by step
If you or a healthcare provider are currently using the Fresenius Medical Care Renal Therapies Group 5008X Standard HD Pre-Flush Standard Blood Tubing Set, the immediate priority is to address the potential for a blood leak. The recall notice highlights a critical safety issue: there is a heightened probability that blood may leak from the connection between the Arterial Alpha Clip and either the main line or the pump segment. Because this tubing is used in hemodialysis treatments, any breach in the system can lead to significant blood loss for the patient, potentially resulting in hypovolemia—a dangerous drop in blood volume that stresses the heart and circulatory system.
The first step in this process is to cease using the specific recalled lots immediately. While the recall announcement from the FDA does not explicitly state whether you should return the item for a refund, repair it, or receive a replacement unit, the standard protocol for Class II device recalls involving potential patient harm is to stop use right away. Do not attempt to fix the tubing yourself, as these are sterile, single-use medical devices designed with precise engineering tolerances. Tampering with the connections could worsen the leak or introduce contaminants. If you are a patient undergoing dialysis, contact your treatment center or nephrologist immediately to inform them that you may have been exposed to this specific batch. They will advise you on how to proceed with your next treatment schedule and ensure your safety.
If you are a healthcare facility administrator or a distributor, you must verify your inventory against the lot numbers provided in the recall notice. The affected products are the 5008X Standard HD Pre-Flush Standard Blood Tubing Set, Part Number 03-5110-6, specifically those from Lots 25KR01227 and 25NR01257. You can also identify these units by their Universal Device Identifier (UDI-DI): 00840861102556. Check your storage areas carefully to locate any remaining stock with these identifiers.
Since the remedy details such as return addresses, refund procedures, or replacement logistics are not stated in the current recall facts, you must reach out directly for guidance. Contact Fresenius Medical Care Renal Therapies Group through their official customer service channels to report your possession of the device and to ask for specific instructions on how they wish you to handle the returned or unused units. They will provide the necessary steps for quarantine, return shipping labels, or credit issuance. Until you speak with them, store any recalled tubing in a secure location away from active treatment areas to prevent accidental use by staff or patients.
Finally, remain vigilant for any updates from the FDA or Fresenius Medical Care regarding this recall. Safety alerts can evolve as more data becomes available. By taking these steps—stopping use, verifying lot numbers, and contacting the manufacturer—you help ensure that no further patients are put at risk of blood loss during dialysis procedures.
Your refund, repair, or replacement options
When a medical device recall occurs, the most immediate concern for patients and healthcare providers is often, "What do I do with this product?" In this specific instance involving Fresenius Medical Care Renal Therapies Group, LLC, we must address a difficult but important reality: the official FDA recall record does not currently list a specific remedy. This means there is no standardized instruction provided in the public filing for a refund, repair, or replacement at this time. It is crucial to understand that the absence of a stated remedy in the initial recall announcement does not mean the issue is being ignored. Rather, it often indicates that the manufacturer is in the early stages of managing the recall logistics, or that the specific corrective action has not yet been disseminated to the public database. For Class II recalls, which involve devices where failure could cause serious health consequences but are not typically life-threatening, manufacturers are required to submit detailed reports to the FDA that often include the planned remedy. However, those details may not be immediately visible in the high-level summary we are referencing.
If you possess the recalled 5008X Standard HD Pre-Flush Standard Blood Tubing Set (Part Number 03-5110-6), particularly if it belongs to lots 25KR01227 or 25NR01257, your first step should not be to guess what you are entitled to, but to seek direct clarification from the responsible party. Since the remedy is not stated in the general record, you must contact Fresenius Medical Care directly. They are the entity responsible for executing the recall and will have the specific, updated instructions regarding whether they are offering a replacement set, a repair kit, or a financial refund. Do not assume that because the remedy isn't listed here, you cannot get help. Contact information for recalls is typically found in the full press release or on the manufacturer's website under their safety or quality assurance sections. When you reach out, have your UDI-DI (00840861102556) and lot numbers ready, as these are the keys to verifying your specific unit against their internal logs.
It is also vital to understand why the remedy might not be explicitly detailed in this summary. In many medical device recalls, especially those involving a heightened probability of a blood leak—a serious hazard that can lead to hypovolemia—the immediate priority is stopping the use of the device rather than processing financial transactions. The "remedy" may effectively be the mandatory cessation of use and the safe disposal or return of the unit for inspection. If a replacement is offered, it will likely come with strict conditions to ensure that the new equipment has been thoroughly tested and verified as safe. Therefore, while we cannot provide you with a direct link to a refund portal or a repair address right now, we can strongly advise that you monitor official channels from Fresenius Medical Care Renal Therapies Group for updated instructions. Until those are available, do not use the recalled tubing set. Your safety is paramount, and waiting for official guidance ensures you receive the correct support without risking further exposure to the identified hazard.
What can happen if you ignore it
When a medical device carries a Class II recall designation, it signals a significant risk to health that requires immediate attention rather than casual observation. In the case of the Fresenius Medical Care 5008X Standard HD Pre-Flush Standard Blood Tubing Set, ignoring this notice is not merely an administrative oversight; it is a direct threat to physiological stability during hemodialysis treatments. The core issue lies in the structural integrity of the connection point between the Arterial Alpha Clip and the main line or pump segment. Under normal circumstances, this junction is designed to withstand the high pressures generated by the dialysis machine’s blood pump. However, the heightened probability of a leak means that this seal may fail unexpectedly, compromising the closed circuit that keeps your blood contained within the sterile tubing.
If you continue to use these recalled lots without replacement, the most immediate and dangerous consequence is a blood leak during treatment. This is not a minor drip or a surface condensation issue. A failure at the arterial clip connection can result in a rapid loss of blood volume from your body back into the dialysis circuit or onto the floor. For patients undergoing hemodialysis, who are often already managing delicate fluid balances and cardiovascular conditions, sudden blood loss can lead to hypovolemia. Hypovolemia occurs when there is too little blood or fluid in the body, causing a dangerous drop in blood pressure and reducing the amount of oxygen reaching your tissues and organs.
The clinical implications of this scenario are severe. A significant leak during treatment can trigger acute hypotension, leading to dizziness, fainting, shock, or even cardiac arrest if the volume loss is substantial enough. Furthermore, the interruption of the dialysis flow means that waste products and excess fluid may not be properly filtered from your blood, prolonging the toxicity buildup that the treatment was meant to address. This double burden—losing vital blood while failing to clear toxins—places an immense strain on the heart and kidneys. Additionally, a breach in the sterile field increases the risk of exposure to pathogens for both the patient and the healthcare staff, turning a routine maintenance procedure into a potential infection control crisis.
It is crucial to understand that these risks are not theoretical. The recall was issued because the probability of this failure mode is elevated beyond acceptable safety thresholds. While the official FDA report does not list specific injury counts for this particular batch as of the recall date, the nature of the hazard—blood loss during a life-sustaining procedure—is inherently high-risk. Waiting for a leak to occur before acting is a dangerous gamble with your health. The integrity of the dialysis circuit is non-negotiable for patient safety, and continuing to use compromised equipment undermines the very purpose of your medical therapy. Immediate cessation of use and contact with your healthcare provider are the only safe paths forward.